DrugPatentWatch Database Preview
Taro Pharm Company Profile
» See Plans and Pricing
What is the competitive landscape for TARO PHARM, and when can generic versions of TARO PHARM drugs launch?
TARO PHARM has fifty-three approved drugs.
There are seven US patents protecting TARO PHARM drugs. There are three tentative approvals on TARO PHARM drugs.
There are twenty patent family members on TARO PHARM drugs in nine countries and forty-nine supplementary protection certificates in fourteen countries.
Summary for Taro Pharm
| International Patents: | 20 |
| US Patents: | 7 |
| Tradenames: | 38 |
| Ingredients: | 36 |
| NDAs: | 53 |
| Patent Litigation for Taro Pharm: | See patent lawsuits for Taro Pharm |
Drugs and US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds Ltd | FLUOCINONIDE EMULSIFIED BASE | fluocinonide | CREAM;TOPICAL | 072494-001 | Jan 19, 1989 | AB2 | RX | No | Yes | Start Trial | Start Trial | ||||
| Taro Pharms | BUTENAFINE HYDROCHLORIDE | butenafine hydrochloride | CREAM;TOPICAL | 205181-001 | Nov 16, 2017 | OTC | No | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | INFANTS' FEVERALL | acetaminophen | SUPPOSITORY;RECTAL | 018337-004 | Aug 26, 1992 | OTC | Yes | No | Start Trial | Start Trial | |||||
| Taro Pharm Inds Ltd | TOPICORT LP | desoximetasone | CREAM;TOPICAL | 018309-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | Start Trial |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | Start Trial |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2009500422 | Start Trial |
| China | 102834096 | Start Trial |
| China | 101287374 | Start Trial |
| Canada | 2822220 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0591275 | SPC/GB05/030 | United Kingdom | Start Trial | PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221 |
| 2506844 | 18C1022 | France | Start Trial | PRODUCT NAME: COMBINAISON COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (EN PARTICULIER LE BROMURE D'UMECLIDINIUM), DU VILANTEROL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (EN PARTICULIER LE TRIFENATATE DE VILANTEROL), ET DU FUROATE DE FLUTICASONE; REGISTRATION NO/DATE: EU/1/17/1236 20171117 |
| 0617614 | 2001/009 | Ireland | Start Trial | PRODUCT NAME: PANRETIN-ALITRETINOIN |
| 0617614 | C300043 | Netherlands | Start Trial | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
